These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30347655)

  • 1. Fullerene Derivatives of Nucleoside HIV Reverse Transcriptase Inhibitors-In Silico Activity Prediction.
    Dąbrowska A; Pieńko T; Taciak P; Wiktorska K; Chilmonczyk Z; Mazurek AP; Stasiulewicz A
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30347655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus-reverse transcriptase inhibition and hepatitis C virus RNA-dependent RNA polymerase inhibition activities of fullerene derivatives.
    Mashino T; Shimotohno K; Ikegami N; Nishikawa D; Okuda K; Takahashi K; Nakamura S; Mochizuki M
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1107-9. PubMed ID: 15686922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring isoxazole and carboxamide derivatives as potential non-nucleoside reverse transcriptase inhibitors.
    Kurup SS; Joshi KA
    J Mol Graph Model; 2016 Apr; 65():113-28. PubMed ID: 26973048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of new potential HIV-1 reverse transcriptase inhibitors by QSAR modeling and structure-based virtual screening.
    Shiri F; Pirhadi S; Rahmani A
    J Recept Signal Transduct Res; 2018 Feb; 38(1):37-47. PubMed ID: 29254400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational drug design strategies applied to the modelling of human immunodeficiency virus-1 reverse transcriptase inhibitors.
    Santos LH; Ferreira RS; Caffarena ER
    Mem Inst Oswaldo Cruz; 2015 Nov; 110(7):847-64. PubMed ID: 26560977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Water-soluble fullerene derivatives for drug discovery.
    Nakamura S; Mashino T
    J Nippon Med Sch; 2012; 79(4):248-54. PubMed ID: 22976602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-silico Studies Show Potent Inhibition of HIV-1 Reverse Transcriptase Activity by a Herbal Drug.
    Seniya C; Yadav A; Khan GJ; Sah NK
    IEEE/ACM Trans Comput Biol Bioinform; 2015; 12(6):1355-64. PubMed ID: 26671807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docking and quantitative structure-activity relationship studies for the bisphenylbenzimidazole family of non-nucleoside inhibitors of HIV-1 reverse transcriptase.
    Lagos CF; Caballero J; Gonzalez-Nilo FD; David Pessoa-Mahana C; Perez-Acle T
    Chem Biol Drug Des; 2008 Nov; 72(5):360-9. PubMed ID: 19012572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What do docking and QSAR tell us about the design of HIV-1 reverse transcriptase nonnucleoside inhibitors?
    Paneth A; Płonka W; Paneth P
    J Mol Model; 2017 Oct; 23(11):317. PubMed ID: 29046967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2,4,5-Trisubstituted thiazole derivatives as HIV-1 NNRTIs effective on both wild-type and mutant HIV-1 reverse transcriptase: Optimization of the substitution of positions 4 and 5.
    Xu Z; Guo J; Yang Y; Zhang M; Ba M; Li Z; Cao Y; He R; Yu M; Zhou H; Li X; Huang X; Guo Y; Guo C
    Eur J Med Chem; 2016 Nov; 123():309-316. PubMed ID: 27484516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Docking and 3-D QSAR studies on indolyl aryl sulfones. Binding mode exploration at the HIV-1 reverse transcriptase non-nucleoside binding site and design of highly active N-(2-hydroxyethyl)carboxamide and N-(2-hydroxyethyl)carbohydrazide derivatives.
    Ragno R; Artico M; De Martino G; La Regina G; Coluccia A; Di Pasquali A; Silvestri R
    J Med Chem; 2005 Jan; 48(1):213-23. PubMed ID: 15634015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fullerene derivatives as dual inhibitors of HIV-1 reverse transcriptase and protease.
    Yasuno T; Ohe T; Kataoka H; Hashimoto K; Ishikawa Y; Furukawa K; Tateishi Y; Kobayashi T; Takahashi K; Nakamura S; Mashino T
    Bioorg Med Chem Lett; 2021 Jan; 31():127675. PubMed ID: 33161121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-enhanced methods in the development of non-nucleoside inhibitors targeting HIV reverse transcriptase variants.
    Frey KM
    Future Microbiol; 2015; 10(11):1767-72. PubMed ID: 26517310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: SAR and Lead Optimization Using CoMFA and CoMSIA Studies (1995-2016).
    Vanangamudi M; Poongavanam V; Namasivayam V
    Curr Med Chem; 2017 Nov; 24(34):3774-3812. PubMed ID: 28685686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular modeling, synthesis and biological evaluation of N-heteroaryl compounds as reverse transcriptase inhibitors against HIV-1.
    Singh A; Yadav D; Yadav M; Dhamanage A; Kulkarni S; Singh RK
    Chem Biol Drug Des; 2015 Mar; 85(3):336-47. PubMed ID: 25055732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deformation density components analysis of fullerene-based anti-HIV drugs.
    Fakhraee S; Souri M
    J Mol Model; 2014 Nov; 20(11):2486. PubMed ID: 25388278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural optimization of N
    Monforte AM; De Luca L; Buemi MR; Agharbaoui FE; Pannecouque C; Ferro S
    Bioorg Med Chem; 2018 Feb; 26(3):661-674. PubMed ID: 29291935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico design, synthesis and anti-HIV activity of quinoline derivatives as non-nucleoside reverse transcriptase inhibitors (NNRTIs).
    Singh VK; Mishra R; Kumari P; Som A; Yadav AK; Ram NK; Kumar P; Schols D; Singh RK
    Comput Biol Chem; 2022 Jun; 98():107675. PubMed ID: 35395595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revealing interaction mode between HIV-1 reverse transcriptase and diaryltriazine analog inhibitor.
    Li Z; Han J; Chen HF
    Chem Biol Drug Des; 2008 Nov; 72(5):350-9. PubMed ID: 19012571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular docking studies on 4-thiazolidinones as HIV-1 RT inhibitors.
    Rawal RK; Kumar A; Siddiqi MI; Katti SB
    J Mol Model; 2007 Jan; 13(1):155-61. PubMed ID: 16969668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.